These results are consistent with previous studies in hepatocellular carcinoma and colon cancer, in which the disruption of ceramide homeostasis by GCS inhibition using RNA interference contributed to a reduction of tumor growth [22,48,49]. The gene discussed is UGCG; the disease is colonic neoplasm.